Announcement
29 Oct 2021
On 29 October 2021, the EIB provided financing worth EUR 15 million (USD 17 million) to support French company Robocath in the development of robotic solutions for treating cardiovascular diseases.
Source
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
Implementation date
29 Oct 2021
Revocation date:
No revocation date
The EIB's EUR 15 million loan (USD 17 million) to Robocath on 29 October 2021 was backed by a guarantee from the Pan-European Guarantee Fund (EGF, see related state act).
The EGF ...
On 29 October 2021, the European Investment Bank (EIB) and French company Robocath Sas signed a loan agreement worth EUR 15 million (approx. USD 17 million) to support Robocath's developm...
See all
This state act is not part of any Thread yet.